Based on bulk RNA-seq, scRNA-seq, and in vitro cell experiments, we have demonstrated, for the first time, that KYNU is overexpressed in GC and is associated with poor prognosis, as well as being an independent risk factor. Here, KYNU is linked to gastric cancer.